Collaboration between Medical Device Companies and Healthcare Institutions is Contributing to the Growth of the Hydrocephalus Shunt Market As per Future Market Insights, Inc.

Hydrocephalus Shunt Market Charts a Strategic Course, anticipating a Slower yet Promising CAGR of 2.40% and a Market Size of US$ 692.25 Million by 2034. Hydrocephalus shunt market Detailed Information About Each Segment and Identify Key Trends, Drivers, and Challenges in the Market

NEWARK, Del, Feb. 20, 2024 (GLOBE NEWSWIRE) -- According to Future Market Insights’ latest industry analysis, the Hydrocephalus Shunt Market size is estimated to be around *US$ 546.09 million *in 2024. It is projected to exhibit a slow-pace CAGR of *2.40%* over the forecast period, reaching an estimated market size of *US$ 692.25 million* in 2034.Hydrocephalus is a condition characterized by the accumulation of excess cerebrospinal fluid in the brain, and its global prevalence has led to a rise in demand for shunt implants, which are used to regulate cerebrospinal fluid levels in the brain. The global healthcare sector, especially hospitals, clinics, and medical facilities, is increasingly adopting hydrocephalus shunts to offer diagnosis, treatment, and follow-up care to patients.

*Request a Sample of this Report Now!*
https://www.futuremarketinsights.com/reports/sample/rep-gb-7756

Hydrocephalus shunts are also increasingly being adopted in rehabilitation centers, providing support and care for hydrocephalus patients who have undergone shunt implantation. Additionally, these shunts are experiencing increasing demand from infants, children, adolescents, and adults diagnosed with hydrocephalus who rely on shunts to manage the condition.

Technological advancements in the medical sector globally have led to the development of safer and more effective shunt devices. Furthermore, collaboration between medical device companies and healthcare institutions has also played a role in promoting market growth for hydrocephalus shunts. Moreover, the expansion of reimbursement policies in developed and developing countries like the United States, India, and the United Kingdom has made hydrocephalus treatment using shunts more accessible.

*“There is still little to no awareness about the benefits of hydrocephalus shunts in underdeveloped parts of the world. Companies in the market must develop comprehensive educational programs for healthcare professionals to familiarize them with the features, benefits, and optimal use of hydrocephalus shunts,” opines *Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

*Key Takeaways from the Hydrocephalus Shunt Market Study*

· The ventriculoperitoneal segment dominates the hydrocephalus shunt market with a market share of *93.45%* in 2024.
· Based on products, the valves segment leads the hydrocephalus shunt industry with a share of *85.24%* in 2024.
· The hydrocephalus shunt market in the United Kingdom is anticipated to grow at a sluggish CAGR of *2.20%* through 2034.
· The hydrocephalus shunt industry in India is estimated to rise at a CAGR of *3.80%* through 2034.
· The hydrocephalus shunt market in China has the potential to increase at a CAGR of *3.50%* through 2034.*Competitive Landscape from the Hydrocephalus Shunt Market*

The hydrocephalus shunt market is highly competitive, with the presence of both international and domestic players catering to various healthcare facilities such as hospitals, clinics, and rehabilitation centers.

Prominent companies such as Medtronic plc, Johnson & Johnson Services, Inc., and B. Braun Melsungen AG have established a strong foothold in the market due to their prolonged presence and widespread reach.

Companies in the hydrocephalus shunt market are investing heavily in research and development to develop innovative products that offer better treatment options and improved patient outcomes.

Key players in the market are also expanding their manufacturing facilities and distribution networks to increase production capacity, improve supply chain efficiency, and reduce lead times.

*Request a Methodology*: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-7756

*Recent Developments in the Hydrocephalus Shunt Market:*

· In June 2020, CereVasc secured US$ 43.9 million in series A financing to develop a minimally invasive alternative for hydrocephalus treatment. The startup, founded by neurosurgeons at Tufts Medical Center, aims to simplify a complex brain procedure and has garnered support from venture capital investors.
· In July 2023, Cerevasc Inc. formed a partnership with Lianmedical Co. Ltd. to introduce its medical devices for neurological diseases in Asia. Lianmedical is now marketing Cerevasc's eshunt system and related products in mainland China, Hong Kong, Taiwan, and Macau, which can facilitate percutaneous transvenous transdural access to the central nervous system.
· In September 2023, Annalise.ai received FDA clearance and breakthrough device designation for its obstructive hydrocephalus CT scan software. This has expanded its AI-powered triage portfolio, and the tool can now assist radiology professionals in prioritizing patients suspected of obstructive hydrocephalus. The software can identify critical findings on non-contrast brain CT scans, which can help in the timely diagnosis and treatment of the condition.*Top 20 Key Companies in the Hydrocephalus Shunt Market*

· Medtronic plc
· Johnson & Johnson Services, Inc.
· B. Braun Melsungen AG
· Sophysa SA
· Integra LifeSciences Corporation
· Spiegelberg GmbH & Co. KG
· Cerevasc Inc.
· Lianmedical Co. Ltd.
· Codman Neuro (a Johnson & Johnson company)
· Miethke GmbH & Co. KG
· Christoph Miethke GmbH & Co. KG
· Natus Medical Incorporated
· Möller Medical GmbH
· Sophysa Ltd.
· NeuroLogica Corp. (a subsidiary of Samsung Electronics)
· DePuy Synthes (a Johnson & Johnson company)
· Mekanika SAS
· Raumedic AG
· SOPHYSA USA LLC
· Chhabra Neurosurgical Products

*Buy Now: *https://www.futuremarketinsights.com/checkout/7756

*Segmentation of Hydrocephalus Shunt Market *

*By Product:*

· Hydrocephalus Valves

· Fixed Pressure Valves
· Adjustable Pressure Valves

· Hydrocephalus Catheters

· Standard Catheters
· Antimicrobial Catheters

*By Procedure Type:*

· Ventriculoperitoneal
· Ventriculoatrial
· Lumboperitoneal
· Ventriculopleural

*By Age Group:*

· Pediatric
· Adults

*By End User:*

· Hospitals
· Specialty Clinics
· Ambulatory Surgical Centers
· Rehabilitation Centers
· Others*By Region:*

· North America
· Latin America
· Asia Pacific
· Middle East and Africa (MEA)
· Europe
*Have a Look at the Related Report from the Hydrocephalus Shunt Market:*

· Pulmonary Fibrosis Biomarker Market is projected to increase from US$ 4,353.0 million in 2024 to US$ 6,538.4 million by 2034. The market was valued at US$ 4,149.0 million in 2023.
· PCSK9 Inhibitor Market size is estimated to reach US$ 2,733.7 million in 2024. It will likely expand at a CAGR of 18.7% during the forecast period, with total sales of PCSK9 inhibitors reaching US$ 15,140.3 million by 2034.
· Laboratory Information System Market size is expected to reach US$ 2,166.3 million in 2024. Driven by a projected 5.3% CAGR over the next decade, the market is set to attain a valuation of US$ 3,620.3 million by 2034.
· Transplant Diagnostics Market is projected to be worth US$ 4.5 billion in 2024. The market is anticipated to reach US$ 8.5 billion by 2034. The market is further expected to surge at a CAGR of 6.5% during the forecast period 2024 to 2034.
· Anatomic Pathology Track and Trace Solution Market is estimated to be worth US$ 2.4 billion by 2034 and is likely to be valued at US$ 807.2 million in 2024. According to the estimates, the demand for anatomic pathology track and trace solutions is projected to clock an 11.5% CAGR until 2034.
· Cell Isolation Market is estimated at US$ 5.1 billion by 2024. The market valuation is expected to be US$ 19.1 billion by 2034, registering an impressive CAGR of 14.1%.
· Veterinary Dental Equipment Market is estimated at US$ 347.3 million by 2024. The market valuation is expected to be US$ 621 million by 2034, registering a moderate CAGR of 6%.
· Coagulation Analyzer Market size is estimated to stand at US$ 4.8 billion in 2024. The market is expected to exceed a valuation of US$ 9.2 billion by 2034, registering a moderate CAGR of 6.6%.
· Empty Capsule Market is projected to be worth US$ 2,956.6 million in 2024. The sales of empty capsules are expected to expand at an 8% CAGR from 2024 to 2034, reaching US$ 6,378.6 million by 2034.
· Dental Diamond Bur Market is estimated to be worth US$ 169.1 million in 2024. By 2034, the market is expected to be valued at US$ 381 million. The market is projected to grow at a CAGR of 8.5% from 2024 to 2034.

*Author*

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

*About Future Market Insights (FMI)*

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

*Contact Us:      *

Nandini Singh Sawlani 

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube